Technical Analysis for TGTX - TG Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 8.15 2.52% 0.20
TGTX closed up 2.52 percent on Tuesday, April 23, 2019, on 68 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical TGTX trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
20 DMA Resistance Bearish 2.52%
1,2,3 Pullback Bullish Bullish Swing Setup 2.52%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.52%
NR7 Range Contraction 2.52%
Inside Day Range Contraction 2.52%
Fell Below 20 DMA Bearish 4.09%
1,2,3 Pullback Bullish Bullish Swing Setup 4.09%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 4.09%
20 DMA Support Bullish 0.12%

Older signals for TGTX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
TG Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of innovative and medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The company is developing two advanced therapies targeting hematological malignancies. The TGTX-1101 (ublituximab) is a novel, third generation monoclonal antibody that targets a specific and unique epitope on the CD20 antigen found on mature B-lymphocytes, which is in clinical development for patients with relapsed and refractory non-Hodgkin's lymphoma. The TGR-1202 is an orally available PI3K delta inhibitor believed to be important in the proliferation and survival of B-lymphocytes. TG Therapeutics, Inc. is headquartered in New York, New York.
Biopharmaceutical Cancer Treatment Of Cancer Monoclonal Antibodies Lymphoma Antibody Drug Conjugates Hematological Malignancies Camidanlumab Tesirine Cd20
Is TGTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 16.0
52 Week Low 3.32
Average Volume 2,565,114
200-Day Moving Average 7.2646
50-Day Moving Average 6.8344
20-Day Moving Average 8.0305
10-Day Moving Average 8.063
Average True Range 0.4957
ADX 39.02
+DI 27.3685
-DI 15.9472
Chandelier Exit (Long, 3 ATRs ) 7.812900000000001
Chandelier Exit (Short, 3 ATRs ) 8.2971
Upper Bollinger Band 8.7128
Lower Bollinger Band 7.3482
Percent B (%b) 0.59
BandWidth 16.992715
MACD Line 0.3219
MACD Signal Line 0.428
MACD Histogram -0.1061
Fundamentals Value
Market Cap 507.83 Million
Num Shares 62.3 Million
EPS -1.95
Price-to-Earnings (P/E) Ratio -4.18
Price-to-Sales 3189.49
Price-to-Book 6.24
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.84
Resistance 3 (R3) 8.79 8.51 8.73
Resistance 2 (R2) 8.51 8.33 8.54 8.69
Resistance 1 (R1) 8.33 8.23 8.42 8.38 8.65
Pivot Point 8.05 8.05 8.10 8.08 8.05
Support 1 (S1) 7.87 7.87 7.96 7.92 7.65
Support 2 (S2) 7.59 7.77 7.62 7.61
Support 3 (S3) 7.41 7.59 7.58
Support 4 (S4) 7.46